Technical Analysis for MRNS - Marinus Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
A 8.24 3.00% 0.24
MRNS closed up 3.0 percent on Thursday, September 28, 2023, on 1.32 times normal volume. It was able to find support at its 50 day moving average. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up

Date Alert Name Type % Chg
50 DMA Support Bullish 0.00%
MACD Bullish Centerline Cross Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Upper Bollinger Band Walk Strength 0.00%
Wide Bands Range Expansion 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 3% about 11 hours ago
50 DMA Support about 12 hours ago
60 Minute Opening Range Breakdown about 13 hours ago
Fell Below 50 DMA about 13 hours ago
Down 2 % about 13 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Marinus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing neuropsychiatric therapeutics. It offers Ganaxolone, a synthetic small molecule, which has completed Phase II clinical trial for the treatment of patients with refractory focal onset seizures; and is in proof-of-concept Phase II clinical trial as a treatment for behaviors in the orphan indication Fragile X Syndrome in children. The company has a collaboration agreement with NovaMedica, LLC, as well as a license agreement with Purdue Neuroscience Company. Marinus Pharmaceuticals, Inc. was founded in 2003 and is headquartered in New Haven, Connecticut.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Drugs Alcohol Neuroscience Ketones Seizure Fragile X Syndrome Sedatives Pregnanes Neurosteroids

Is MRNS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 11.15
52 Week Low 3.465
Average Volume 723,336
200-Day Moving Average 7.45
50-Day Moving Average 7.89
20-Day Moving Average 7.01
10-Day Moving Average 7.08
Average True Range 0.59
RSI (14) 60.47
ADX 19.98
+DI 32.84
-DI 18.77
Chandelier Exit (Long, 3 ATRs) 6.50
Chandelier Exit (Short, 3 ATRs) 7.56
Upper Bollinger Bands 8.18
Lower Bollinger Band 5.83
Percent B (%b) 1.02
BandWidth 33.53
MACD Line 0.00
MACD Signal Line -0.25
MACD Histogram 0.248
Fundamentals Value
Market Cap 252.1 Million
Num Shares 30.6 Million
EPS -0.98
Price-to-Earnings (P/E) Ratio -8.39
Price-to-Sales 1962.98
Price-to-Book 5.65
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.18
Resistance 3 (R3) 9.08 8.68 9.02
Resistance 2 (R2) 8.68 8.44 8.72 8.97
Resistance 1 (R1) 8.46 8.29 8.57 8.55 8.92
Pivot Point 8.05 8.05 8.11 8.10 8.05
Support 1 (S1) 7.83 7.81 7.94 7.93 7.56
Support 2 (S2) 7.43 7.67 7.47 7.51
Support 3 (S3) 7.21 7.43 7.46
Support 4 (S4) 7.30